BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21960226)

  • 1. Measuring phosphorylation-specific changes in response to kinase inhibitors in mammalian cells using quantitative proteomics.
    Ozlü N; Kirchner M; Steen JJ
    Methods Mol Biol; 2012; 795():217-31. PubMed ID: 21960226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinase inhibitor profiling using chemoproteomics.
    Schirle M; Petrella EC; Brittain SM; Schwalb D; Harrington E; Cornella-Taracido I; Tallarico JA
    Methods Mol Biol; 2012; 795():161-77. PubMed ID: 21960222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring phosphoproteomic response to targeted kinase inhibitors using reverse-phase protein microarrays.
    Lavezzari G; Lackner MR
    Methods Mol Biol; 2012; 795():203-15. PubMed ID: 21960225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome-wide identification of staurosporine-binding kinases using capture compound mass spectrometry.
    Fischer JJ; Graebner Neé Baessler OY; Dreger M
    Methods Mol Biol; 2012; 795():135-47. PubMed ID: 21960220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.
    Daub H; Olsen JV; Bairlein M; Gnad F; Oppermann FS; Körner R; Greff Z; Kéri G; Stemmann O; Mann M
    Mol Cell; 2008 Aug; 31(3):438-48. PubMed ID: 18691976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
    Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
    J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC).
    Amanchy R; Kalume DE; Iwahori A; Zhong J; Pandey A
    J Proteome Res; 2005; 4(5):1661-71. PubMed ID: 16212419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation.
    Yang F; Stenoien DL; Strittmatter EF; Wang J; Ding L; Lipton MS; Monroe ME; Nicora CD; Gristenko MA; Tang K; Fang R; Adkins JN; Camp DG; Chen DJ; Smith RD
    J Proteome Res; 2006 May; 5(5):1252-60. PubMed ID: 16674116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ProteoConnections: a bioinformatics platform to facilitate proteome and phosphoproteome analyses.
    Courcelles M; Lemieux S; Voisin L; Meloche S; Thibault P
    Proteomics; 2011 Jul; 11(13):2654-71. PubMed ID: 21630457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity purification of proteins binding to kinase inhibitors immobilized on self-assembling monolayers.
    Bantscheff M; Hobson S; Kuster B
    Methods Mol Biol; 2012; 795():149-60. PubMed ID: 21960221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and proteomic identification of putative upstream regulators of polo-like kinase-1 from mitotic cell extracts.
    Ji JH; Hwang HI; Lee HJ; Hyun SY; Kang HJ; Jang YJ
    FEBS Lett; 2010 Oct; 584(20):4299-305. PubMed ID: 20869364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteome and phosphoproteome analyses of cultured cells based on SILAC labeling without requirement of serum dialysis.
    Imami K; Sugiyama N; Tomita M; Ishihama Y
    Mol Biosyst; 2010 Mar; 6(3):594-602. PubMed ID: 20174688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoproteomic characterization of protein kinase inhibitors using immobilized ATP.
    Duncan JS; Haystead TA; Litchfield DW
    Methods Mol Biol; 2012; 795():119-34. PubMed ID: 21960219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry-based quantitative proteomics.
    Heck AJ; Krijgsveld J
    Expert Rev Proteomics; 2004 Oct; 1(3):317-26. PubMed ID: 15966828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking the kinome and phosphorylome--a comprehensive review of approaches to find kinase targets.
    Sopko R; Andrews BJ
    Mol Biosyst; 2008 Sep; 4(9):920-33. PubMed ID: 18704230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of histone deacetylase-1 selective histone modifications by differential mass spectrometry.
    Lee AY; Paweletz CP; Pollock RM; Settlage RE; Cruz JC; Secrist JP; Miller TA; Stanton MG; Kral AM; Ozerova ND; Meng F; Yates NA; Richon V; Hendrickson RC
    J Proteome Res; 2008 Dec; 7(12):5177-86. PubMed ID: 19367703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charging it up: global analysis of protein phosphorylation.
    Ptacek J; Snyder M
    Trends Genet; 2006 Oct; 22(10):545-54. PubMed ID: 16908088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomics to study mitogen-activated protein kinases.
    Blagoev B; Mann M
    Methods; 2006 Nov; 40(3):243-50. PubMed ID: 17071406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining Cellular Responses to Kinase Drug Inhibition Through Phosphoproteome Mapping of Substrates.
    Bucio-Noble D; Semaan C; Molloy MP
    Methods Mol Biol; 2019; 1888():141-152. PubMed ID: 30519945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.
    Rush J; Moritz A; Lee KA; Guo A; Goss VL; Spek EJ; Zhang H; Zha XM; Polakiewicz RD; Comb MJ
    Nat Biotechnol; 2005 Jan; 23(1):94-101. PubMed ID: 15592455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.